Evidence map›Paper›PMID 21765997›Full record

ArticleJournal of thyroid research2011

Thyroid hormone and cardiac disease: from basic concepts to clinical application.

Iordanis Mourouzis, Francesca Forini, Constantinos Pantos, Giorgio Iervasi

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Journal of thyroid research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02512978 (Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction), which is not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02512978 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Thyroid Hormone Replacement for Hypothyroidism and Acute Myocardial Infarction

TypeinterventionalSponsorChinese Academy of Medical Sciences, Fuwai HospitalRan2015 to 2019Enrolled160ConditionsMyocardial Infarction, HypothyroidismArmsLevothyroxine
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Thyroid hormones and cardiovascular disease.Nature reviews. Cardiology · 2017
    Review
  10. Review
  11. Review
  12. Cardioprotection and thyroid hormones.Heart failure reviews · 2016
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Iordanis MourouzisDepartment of Pharmacology, University of Athens, 11527 Athens, Greece.
Francesca Forini
Constantinos Pantos
Giorgio Iervasi
Fondazione Toscana Gabriele Monasterio · ITNational and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nature's models of regeneration provide substantial evidence that a natural healing process may exist in the heart. Analogies existing between the damaged myocardium and the developing heart strongly indicate that regulatory factors which drive embryonic heart development may also control aspects of heart regeneration. In this context, thyroid hormone (TH) which is critical in heart maturation during development appears to have a reparative role in adult life. Thus, changes in TH -thyroid hormone receptor (TR) homeostasis are shown to govern the return of the damaged myocardium to the fetal phenotype. Accordingly, thyroid hormone treatment preferentially rebuilds the injured myocardium by reactivating developmental gene programming. Clinical data provide further support to this experimental evidence and changes in TH levels and in particular a reduction of biologically active triiodothyronine (T3) in plasma after myocardial infarction or during evolution of heart failure, are strongly correlated with patients morbidity and mortality. The potential of TH to regenerate a diseased heart has now been testing in patients with acute myocardial infarction in a phase II, randomized, double blind, placebo-controlled study (the THiRST study).

Identifiers

PMID21765997
PMCPMC3134399
OpenAlexW2135009630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.